Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Sell

Price to Earnings Rating

Strong Sell

Analyst Rating

Sell

Simple Moving Average

Sell

Exponential Moving Average

Strong Sell

Relative Strength Index

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Sell

C

Aditxt, Inc. Common Stock (ADTX)

Pharmaceutical Preparations

https://www.aditxt.com

Aditxt Inc is a life sciences company that develops, builds, and grows innovations with a focus on monitoring and modulating the immune system. It develops products designed to induce tolerance to transplanted organs. Its portfolio consists of two programs Adimune and AditxtScore. It firm's immunosuppressive (anti-rejection) drugs have made possible life-saving organ transplantation procedures as these drugs prevent or delay organ rejection. It is also developing a technology called Apoptotic DNA Immunotherapy (ADi) which utilizes a tolerogenic approach that utilizes the body's natural process of cell death, to deliver a modified antigen that signals the immune system to become tolerant to transplanted tissues.

737 N. FIFTH STREET, SUITE 200
RICHMOND, VA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

06/30/2020

Market Cap

3,702,852

Shares Outstanding

1,250,000

Weighted SO

491,851

Total Employees

N/A

Upcoming Earnings

N/A

Similar Tickers

NRBO --.--%

DRMA --.--%

UNCY --.--%

REVB --.--%

PALI --.--%

PSTV --.--%

QNRX --.--%

ALLR --.--%

KRBP --.--%

Beta

1.0110

Last Div

0.0000

Range

0.89-68.08

Chg

0.0100

Avg Vol

2438374

Mkt Cap

3702852

Exch

NASDAQ

Country

US

Phone

909 488 0844

DCF Diff

N/A

DCF

0.0000

Div Yield

0.0000

P/S

7.3115

EV Multiple

-0.3742

P/FV

0.1833

Div Yield %

0.0000

P/E

-0.0443

PEG

-0.0026

Payout

0.0000

Current Ratio

0.0922

Quick Ratio

0.0562

Cash Ratio

0.0051

DSO

307.7773

DIO

246.8047

Op Cycle

554.5820

DPO

3709.6634

CCC

-3155.0814

Gross Margin

-0.8186

Op Margin

-62.8231

Pretax Margin

-81.4990

Net Margin

-81.2056

Eff Tax Rate

-0.0005

ROA

-1.4701

ROE

-9.1923

ROCE

-2.9809

NI/EBT

0.9964

EBT/EBIT

1.2973

EBIT/Rev

-62.8231

Debt Ratio

0.2890

D/E

0.8142

LT Debt/Cap

0.0824

Total Debt/Cap

0.4488

Int Coverage

-3.4201

CF/Debt

-2.5460

Equity Multi

2.8172

Rec Turnover

1.1859

Pay Turnover

0.0984

Inv Turnover

1.4789

FA Turnover

0.1278

Asset Turnover

0.0181

OCF/Share

-12.7794

FCF/Share

-12.7852

Cash/Share

0.0550

OCF/Sales

-40.6483

FCF/OCF

1.0005

CF Coverage

-2.5460

ST Coverage

-2.8616

CapEx Coverage

-2199.8238

Div&CapEx Cov

-2199.8238

P/BV

0.1833

P/B

0.1833

P/S

7.3115

P/E

-0.0443

P/FCF

-0.1798

P/OCF

-0.0884

P/CF

-0.0884

PEG

-0.0026

P/S

7.3115

EV Multiple

-0.3742

P/FV

0.1833

DPS

0.0000

Latest Headlines (EST)

Benzinga Dec 12, 14:23 Crude Oil Down 4%; Aditxt Shares Spike Higher Benzinga Dec 12, 11:58 Dow Jumps Over 100 Points; Oracle Posts Mixed Q2 Results

Revenue Product Segmentation